| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| 250mg |
|
||
| Other Sizes |
|
Fabomotizole hydrochloride (CM346; Afobazole) is a novel, potent and selective anxiolytic drug that produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions. It was launched in Russia in the early 2000s. It produces anxiolytic and neuroprotective effects without any sedative or muscle relaxant actions. Its mechanism of action remains poorly defined however, with GABAergic, NGF- and BDNF-release-promoting, MT1 receptor agonism, MT3 receptor antagonism, and sigma agonism suggested as potential mechanisms. Fabomotizole was shown to inhibit MAO-A reversibly and there might be also some involvement with serotonin receptors. Clinical trials have shown fabomotizole to be well tolerated and reasonably effective for the treatment of anxiety.
| ln Vitro |
Afobazole's exact mode of action is still unknown, although possible mechanisms include sigma agonism, MT1 receptor antagonism, GABAergic stimulation, NGF and BDNF release promotion, and MT1 receptor antagonism. Alfobazole may also be connected to serotonin receptors in addition to its demonstrated ability to reversibly inhibit MAO-A. Outside of Russia, azobazole is rarely used clinically, and the FDA has not reviewed this medication.
|
|---|---|
| References |
[1]. Afobazole, From Wikipedia
|
| Additional Infomation |
See also: Fabomotizole (annotation moved to).
|
| Molecular Formula |
C₁₅H₂₂CLN₃O₂S
|
|---|---|
| Molecular Weight |
343.872081279755
|
| Exact Mass |
343.112
|
| CAS # |
173352-39-1
|
| Related CAS # |
Fabomotizole;173352-21-1
|
| PubChem CID |
9862936
|
| Appearance |
Light yellow to yellow solid powder
|
| LogP |
3.125
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
5
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
22
|
| Complexity |
315
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
Cl.S(C1=NC2C=CC(=CC=2N1)OCC)CCN1CCOCC1
|
| InChi Key |
MYSRFAUFQZYTOV-UHFFFAOYSA-N
|
| InChi Code |
1S/C15H21N3O2S.ClH/c1-2-20-12-3-4-13-14(11-12)17-15(16-13)21-10-7-18-5-8-19-9-6-18/h3-4,11H,2,5-10H2,1H3,(H,16,17)1H
|
| Chemical Name |
4-(2-((5-ethoxy-1H-benzo[d]imidazol-2-yl)thio)ethyl)morpholine hydrochloride
|
| Synonyms |
CM346
Afobazol HCl, CM 346Afobazol Hydrochloride CM-346 Fabomotizole Afobazole
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O : ~100 mg/mL (~290.81 mM)
DMSO : ≥ 44 mg/mL (~127.96 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 50 mg/mL (145.40 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.9081 mL | 14.5404 mL | 29.0808 mL | |
| 5 mM | 0.5816 mL | 2.9081 mL | 5.8162 mL | |
| 10 mM | 0.2908 mL | 1.4540 mL | 2.9081 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
